BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26662714)

  • 21. Basal cell carcinomas in mice overexpressing Gli2 in skin.
    Grachtchouk M; Mo R; Yu S; Zhang X; Sasaki H; Hui CC; Dlugosz AA
    Nat Genet; 2000 Mar; 24(3):216-7. PubMed ID: 10700170
    [No Abstract]   [Full Text] [Related]  

  • 22. Analyses of the tumour suppressor ING1 expression and gene mutation in human basal cell carcinoma.
    Chen B; Campos EI; Crawford R; Martinka M; Li G
    Int J Oncol; 2003 Apr; 22(4):927-31. PubMed ID: 12632089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the Sonic hedgehog pathway in squamous cell carcinoma of the skin and the mucosa of the head and neck.
    Schneider S; Thurnher D; Kloimstein P; Leitner V; Petzelbauer P; Pammer J; Brunner M; Erovic BM
    Head Neck; 2011 Feb; 33(2):244-50. PubMed ID: 20848446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid receptor isoform mRNA expression differs between BCC and SCC of the skin.
    Hartmann F; Kosmidis M; Mühleisen B; French LE; Hofbauer GF
    Arch Dermatol; 2010 Jun; 146(6):675-6. PubMed ID: 20566936
    [No Abstract]   [Full Text] [Related]  

  • 25. The glutathione-S-transferase P1 polymorphisms correlates with changes in expression of TP53 tumor suppressor in cutaneous basal cell carcinoma.
    Gorji H; Shahbazi N; Habibollahi P; Tavangar SM; Firooz A; Ghahremani MH
    J Dermatol Sci; 2009 Dec; 56(3):208-10. PubMed ID: 19800766
    [No Abstract]   [Full Text] [Related]  

  • 26. Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma.
    Amin SH; Tibes R; Kim JE; Hybarger CP
    Laryngoscope; 2010 Dec; 120(12):2456-9. PubMed ID: 20927781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of apoptosis in basal cell and squamous cell carcinoma formation.
    Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
    Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonmelanoma skin cancer of the head and neck: molecular mechanisms.
    Cobanoglu HB; Constantinides M; Ural A
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):437-43. PubMed ID: 23084296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16 gene expression in basal cell carcinoma.
    Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
    Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
    Yan L; Chen M; Yu G
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy in basal cell carcinoma. Complete remission of locally advanced basal cell carcinoma following treatment with chemotherapy containing cis-platinum].
    Pfeiffer P; Hansen O; Rose C
    Ugeskr Laeger; 1989 Aug; 151(34):2150-1. PubMed ID: 2773150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
    Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metatypical basaloma. A case report].
    Rodiek SO
    Radiologe; 1983 Oct; 23(10):480-2. PubMed ID: 6647834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma.
    Bäckvall H; Strömberg S; Gustafsson A; Asplund A; Sivertsson A; Lundeberg J; Ponten F
    Exp Dermatol; 2004 Oct; 13(10):643-50. PubMed ID: 15447725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin.
    Takeuchi T; Liang SB; Ohtsuki Y
    Mol Carcinog; 2002 Dec; 35(4):173-9. PubMed ID: 12489108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xeroderma pigmentosum complementation group C protein (XPC) expression in basal cell carcinoma.
    Yang LC; Hsiao YP; Lu CT; Huang CH; Chao WR; Lin YT; Su HA; Chang SL; Chung JG
    In Vivo; 2015; 29(1):35-8. PubMed ID: 25600527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers.
    Xu K; Mao X; Mehta M; Cui J; Zhang C; Xu Y
    PLoS One; 2012; 7(1):e30750. PubMed ID: 22295108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization.
    Kanjilal S; Strom SS; Clayman GL; Weber RS; el-Naggar AK; Kapur V; Cummings KK; Hill LA; Spitz MR; Kripke ML
    Cancer Res; 1995 Aug; 55(16):3604-9. PubMed ID: 7627969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvessel density and VEGF expression seems to correlate with invasiveness of basal cell carcinoma.
    Carbone A; Viola P; Varrati S; Angelucci D; Tulli A; Amerio P
    Eur J Dermatol; 2011; 21(4):608-9. PubMed ID: 21865111
    [No Abstract]   [Full Text] [Related]  

  • 40. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
    Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.